Skip to main content
Displaying 1 - 12 of 15
Display:
12
24
48
Liver Tumours
4
Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024
View
Liver Tumours
4
Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024
View
Liver Tumours
4
Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024
View
Liver Tumours
4
Roche: Unveiling the key factors: critical aspects in HCC treatment today - EASL Liver Cancer Summit 2024
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Liver Tumours
5
Roche: Reigniting progress in the HCC treatment landscape - Digital Liver Cancer Summit 2021
View
Metabolism, Alcohol & Toxicity
1
Bristol Myers Squibb: NASH: An evolution in treatment response tools - ILC 2021
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Liver Tumours
5
Bristol-Myers Squibb: Evolving Treatment Landscape of HCC - Digital ILC 2020
View
Pagination
Current page
1
Page
2
Next page
next ›
Last page
Last »
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy